* »çÀüµî·Ï±â°£ÀϱîÁöÀÇ Çùȸ ȸ¿øµî±Þ¿¡ ÁØÇÔ. »çÀüµî·Ï ¸¶°¨ ÈÄ È¸¿øµî±ÞÀ» º¯°æÇÏ¿©µµ º¸¼ö±³À° ÇÐÁ¡ ÀÎÁ¤ ºÒ°¡
Âü°í: ´çÇØ¿¬µµ ÀÛ¾÷Ä¡·á»ç ½Å±Ô¸éÇãÃëµæÀÚ´Â º¸¼ö±³À° ¸éÁ¦´ë»óÀ̸ç, ÀÛ¾÷Ä¡·áÇаú ±³¼ö·Î ÀçÁ÷ ÁßÀÎ °æ¿ì(°âÀÓ±³¼ö Á¦¿Ü)º¸¼ö±³À° À¯¿¹´ë»óÀ̹ǷΠº¸¼ö±³À° ÀÎÁ¤ ½ÅûÀ» ÇÏÁö ¾Ê¾Æµµ µÊ. (»ç)´ëÇÑÀÛ¾÷Ä¡·á»çÇùȸ ȨÆäÀÌÁö ¸éÇã½Å°í½Ã½ºÅÛ¿¡¼ º¸¼ö±³À° ¸éÁ¦(À¯¿¹)½ÅûÀ» ÇÒ ¼ö ÀÖÀ½.
ÀÛ¾÷Ä¡·á»ç *(»ç)´ëÇÑÀÛ¾÷Ä¡·á»çÇùȸ Æò»ýȸ¿ø, Á¤È¸¿ø¸¸ ÀÎÁ¤ |
»çÀüµî·Ï | |
---|---|---|
º¸¼ö±³À° ¹Ì½Åû | º¸¼ö±³À° ½Åû | |
´ëÇÑ¿¬ÇÏÀå¾ÖÇÐȸ Á¤È¸¿ø (2021³â ¿¬È¸ºñ 20,000¿ø ³³ºÎ ȸ¿ø) |
20,000¿ø | 29,000¿ø |
´ëÇÑ¿¬ÇÏÀå¾ÖÇÐȸ ºñȸ¿ø | 50,000¿ø | 59,000¿ø |
±¸ºÐ | ¿¬È¸ºñ | Æò»ýȸºñ | ºñ°í |
---|---|---|---|
Æò»ýȸ¿ø | - | 300,000 | - |
Á¤È¸¿ø | 30,000 | - | Àü¹®ÀÇ |
20,000 | - | ÀÛ¾÷Ä¡·á»ç, ¿µ¾ç»ç, °£È£»ç, ±âŸ ¿¬ÇÏÀå¾Ö ºÐ¾ß Á¾»çÀÚ µî |
|
ÁØȸ¿ø | 20,000 | - | Àü°øÀÇ |
10,000 | - | ÇкΠ¹× ´ëÇпø °úÁ¤ Çлý (ÀÇ·á ÀÚ°ÝÁõÀÌ ¾ø´Â Çлý) |
* º¸¼ö±³À°À¸·Î ÀÎÁ¤µÇ´Â Session °ÀǸ¦ ¹Ýµå½Ã ¼ö°ÇØ¾ß ÇÕ´Ï´Ù.
Á¦11ȸ Ãá°èÇмú´ëȸ ÀÛ¾÷Ä¡·á»ç º¸¼ö±³À° ÀÎÁ¤ °ÀÇ : Session ¥±. Head and Neck Cancer, Session ¥². Progressive Disease
°Á | º¸¼ö±³À° ÀÎÁ¤½Ã°£ | º¸¼ö±³À° Ãâ°áÈ®ÀÎ |
---|---|---|
¥°. COVID-19 | x | O |
¥±. Head and Neck Cancer | O | O |
¥². Progressive Disease | O | O |
* Session II, Session ¥² ÀüºÎ ¼ö°ÇÏ¿© º¸¼ö±³À° ÀÎÁ¤
°Á | º¸¼ö±³À° ÀÎÁ¤½Ã°£ | º¸¼ö±³À° Ãâ°áÈ®ÀÎ |
---|---|---|
¥°. COVID-19 | x | x |
¥±. Head and Neck Cancer | O | O |
¥². Progressive Disease | O | O |
* º¸¼ö±³À° ÇÐÁ¡ ÀÎÁ¤ °ÀÇÀÎ Session II, Session ¥²¸¦ ¼ö°ÇÏ¿© ÇÐÁ¡ ÀÎÁ¤
* Session II, Session ¥²¸¦ ÀüºÎ ¼ö°ÇÏ¿©¾ß º¸¼ö±³À°ÀÌ ÀÎÁ¤µÇ¸ç, Ãâ°áÈ®ÀÎÀ» ¹Ýµå½Ã ÇÏ¿©¾ß ÇÕ´Ï´Ù.
°Á | º¸¼ö±³À° ÀÎÁ¤½Ã°£ | º¸¼ö±³À° Ãâ°áÈ®ÀÎ |
---|---|---|
¥°. COVID-19 | x | O |
¥±. Head and Neck Cancer | O | x |
¥². Progressive Disease | O | O |
* Session¥°¿Í Session ¥²¸¸ ¼ö°ÇÏ¿´À» °æ¿ì, Session II¸¦ ¼ö°ÇÏÁö ¾Ê¾Æ ÇÐÁ¡ ºÒÀÎÁ¤ ó¸®.